Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteoporosis in multiple myeloma].

A Sakalová1, Z Herrmann, S Gazová

  • 1Klinika hematológie a transfuziológie FN, Bratislava.

Vnitrni Lekarstvi
|July 28, 1999
PubMed
Summary

Accurate diagnosis of bone changes is crucial for patients over 50, especially those with multiple myeloma. Early osteoporosis detection and treatment can stabilize or improve bone health, preventing further osteolysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors influencing overall survival and GvHD development after allogeneic hematopoietic stem cell transplantation - single centre experience.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2024
Same author

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Allergy·2023
Same author

Cardiovascular complications among hematopoietic cell transplantation survivors - the role of cardiomarkers.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2022
Same author

Influence of different spectra of NOTCH3 variants on the clinical phenotype of CADASIL - experience from Slovakia.

Neurogenetics·2022
Same author

Metabolic syndrome in long-term survivors after allogeneic hematopoietic stem cell transplantation.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2022
Same author

Humoral immune responses against facultative pathogen Candida utilis in atopic patients with vulvovaginal candidiasis. Candida utilis glucomannan - New serologic biomarker.

Immunobiology·2021

Area of Science:

  • Oncology
  • Rheumatology
  • Pharmacology

Context:

  • Osteoporosis is a global health issue, particularly affecting individuals over 50.
  • This demographic is also at increased risk for multiple myeloma and other malignancies.
  • Distinguishing between malignant and benign osteoporosis is essential for effective management.

Purpose:

  • To evaluate the efficacy of biphosphonates and chemotherapy in managing bone disease in multiple myeloma patients.
  • To highlight the importance of accurate diagnosis of osseous changes in this patient group.

Summary:

  • A retrospective analysis of 151 multiple myeloma patients treated with chemotherapy, immunomodulating drugs, and biphosphonates over 2-3 years was conducted.
  • At diagnosis, 24.5% of patients presented with osteoporosis as the sole bone finding.

Related Experiment Videos

  • During a three-year observation period with biphosphonates and chemotherapy, bone processes remained stable in 61.59%, improved in 11.26%, and progressed in 27.15%.

    • Impact:

    • Emphasizes the critical role of precise diagnosis in managing bone complications associated with multiple myeloma.
    • Suggests that combined treatment regimens including biphosphonates can positively influence bone health in myeloma patients.
    • Underscores that osseous changes can progress even in clinically asymptomatic myeloma, necessitating vigilant monitoring.